Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Gingivitis - Overview
Gingivitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Gingivitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Gingivitis - Companies Involved in Therapeutics Development
Amyndas Pharmaceuticals LLC
Avican Inc
Pacgen Life Science Corp
Gingivitis - Drug Profiles
AMY-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BLXA-4ME - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KSL-W - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
P-113 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Agonize CB1 and CB2 for Gingivitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gingivitis - Dormant Projects
Gingivitis - Product Development Milestones
Featured News & Press Releases
Mar 09, 2021: Amyndas announces positive top-line phase 2 results for investigatiol AMY-101 in adults with periodontal inflammation and gingivitis
Aug 26, 2019: Amyndas Pharmaceuticals initiates phase 2a study of AMY-101 in adults with periodontal inflammation and gingivitis
Jan 24, 2017: Pacgen announces new markets for P113 products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Gingivitis, 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Gingivitis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Gingivitis - Pipeline by Amyndas Pharmaceuticals LLC, 2021
Gingivitis - Pipeline by Avicanna Inc, 2021
Gingivitis - Pipeline by Pacgen Life Science Corp, 2021
Gingivitis - Dormant Projects, 2021